Skip to content

The use of a Therapeutic Tool to reduce symptoms of Depression

The use of Biofeedback in reducing depressive symptoms in users of Psychiatric Outpatient Clinic and Psychosocial Care Center: a randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5prgcn
Enrollment
Unknown
Registered
2018-05-07
Start date
2018-06-06
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

The participants of the experimental group (17 people) will be submitted to biofeedback training, maintaining the standard treatment for depression. The control group (17 people) will receive only con
in this group, the usual interventions provided by the service will be maintained
Device

Sponsors

Universidade Federal de Alagoas
Lead Sponsor
Universidade Federal de Alagoas
Collaborator

Eligibility

Age
18 Years to 110 Years

Inclusion criteria

Inclusion criteria: 18 years of age or older; being accompanied in the service due to depression; being on medication for depression; meet the criteria of the International Neuropsychiatric Interview (MINI) for depression; present scores from 20 to 63 of the Beck Depression Inventory (BDI)

Exclusion criteria

Exclusion criteria: Persons in acute stage of hallucination and dissociation; in dependence on psychoactive substances, except nicotine

Design outcomes

Primary

MeasureTime frame
Expected outcome 1: Reduction of depressive symptoms, evaluated by the Beck Depression Inventory, from the observation of a variation of at least 5% in the pre and post-intervention measurements;Expected outcome 2: Reduction of suicide risk, evaluated by the Suicidal ideation scale, from the observation of a variation of at least 5% in the pre and post-intervention measurements ;Expected outcome 3: Improvement in hopelessness rating, assessed by the Beck Hopelessness Scale, from the observation of a variation of at least 5% in the pre and post-intervention measurements;Expected outcome 4: Improvement in anxiety rating, assessed by the Beck Anxiety Inventory, from the observation of a variation of at least 5% in the pre and post-intervention measurements

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactMaria Cicera;Willams Henrique de Albuquerque;da Costa Maynart

Universidade Federal de Alagoas;Universidade Federal de Alagoas

cicera.albuquerque@esenfar.ufal.br;willamshcmaynart@hotmail.com+55(82)988124544;+55(82)996087074

Outcome results

None listed

Source: REBEC (via WHO ICTRP)